Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis-Reference-Cited by-同舟云学术

Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis

Published:2017-11 Issue: Volume:86 Page:248-256
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Franklin Cindy,Rooms Isabelle,Fiedler Melanie,Reis Henning,Milsch Laura,Herz Saskia,Livingstone Elisabeth,Zimmer Lisa,Schmid Kurt Werner,Dittmer Ulf,Schadendorf Dirk,Schilling Bastian

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference31 articles.

1. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

2. Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma;Schadendorf;J Clin Oncol,2015

3. Pembrolizumab versus ipilimumab in advanced melanoma;Robert;N Engl J Med,2015

4. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N Engl J Med,2015

5. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial;Weber;Lancet Oncol,2015

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two Cases of Cytomegalovirus Colitis During the Treatment of Immune Checkpoint Inhibitor-Associated Colitis;Cureus;2024-06-27

2. The role of immune checkpoint inhibitors in the development and treatment of infectious processes;Journal of Clinical Practice;2024-04-17

3. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU;Gastroenterología y Hepatología;2024-04

4. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU;Gastroenterología y Hepatología (English Edition);2024-04

5. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU;Revista Española de Enfermedades Digestivas;2024